High HSP90 expression is associated with decreased survival in breast cancer.
about
Heat shock protein-90-alpha, a prolactin-STAT5 target gene identified in breast cancer cells, is involved in apoptosis regulationHeat shock proteins as danger signals for cancer detectionTargeting Cell Survival Proteins for Cancer Cell DeathThe Hsp90 inhibitor IPI-504 rapidly lowers EML4-ALK levels and induces tumor regression in ALK-driven NSCLC models.Nuclear heat shock protein 110 expression is associated with poor prognosis and chemotherapy resistance in gastric cancer.Molecular Mechanisms and Translational Therapies for Human Epidermal Receptor 2 Positive Breast CancerAmplification and high-level expression of heat shock protein 90 marks aggressive phenotypes of human epidermal growth factor receptor 2 negative breast cancerLosses of chromosome 5q and 14q are associated with favorable clinical outcome of patients with gastric cancerRole of acetylation and extracellular location of heat shock protein 90alpha in tumor cell invasionSystematic Proteomic Identification of the Heat Shock Proteins (Hsp) that Interact with Estrogen Receptor Alpha (ERα) and Biochemical Characterization of the ERα-Hsp70 InteractionTherapeutic potential of HSP90 inhibition for neurofibromatosis type 2.Targeting highly expressed extracellular HSP90 in breast cancer stem cells inhibits tumor growth in vitro and in vivo.Heat shock protein90 in lobular neoplasia of the breast.Influenza virus infection elicits protective antibodies and T cells specific for host cell antigens also expressed as tumor-associated antigens: a new view of cancer immunosurveillance.An optimized, broadly applicable piggyBac transposon induction systemOverexpression of heat-shock factor 1 is associated with a poor prognosis in esophageal squamous cell carcinomaHsp90 in the continuum of breast ductal carcinogenesis: Evaluation in precursors, preinvasive and ductal carcinoma lesionsDecreased Hsp90 expression in infiltrative lobular carcinoma: an immunohistochemical study.Proteomic analysis of proteome and histone post-translational modifications in heat shock protein 90 inhibition-mediated bladder cancer therapeutics.Molecular stress-inducing compounds increase osteoclast formation in a heat shock factor 1 protein-dependent mannerNetwork pharmacology-based and clinically relevant prediction of the active ingredients and potential targets of Chinese herbs in metastatic breast cancer patients.Protein signature for non-small cell lung cancer prognosis.Structure-based virtual screening and molecular docking for the identification of potential multi-targeted inhibitors against breast cancer.HSP90 inhibitor AUY922 can reverse Fulvestrant induced feedback reaction in human breast cancer cellsPotential prognostic value of heat-shock protein 90 in the presence of phosphatidylinositol-3-kinase overexpression or loss of PTEN, in invasive breast cancers.Effect of the secretory small GTPase Rab27B on breast cancer growth, invasion, and metastasis.Angiogenesis inhibitors: current strategies and future prospects.Hsp90 inhibition differentially destabilises MAP kinase and TGF-beta signalling components in cancer cells revealed by kinase-targeted chemoproteomics.Proteomic analyses reveal high expression of decorin and endoplasmin (HSP90B1) are associated with breast cancer metastasis and decreased survival.Treating breast cancer in the 21st century: emerging biological therapiesRedox regulation of the stability of the SUMO protease SENP3 via interactions with CHIP and Hsp90.Geldanamycin selectively targets the nascent form of ERBB3 for degradationCalreticulin expression in infiltrating ductal breast carcinomas: relationships with disease progression and humoral immune responses.The epidermal growth factor receptor family: biology driving targeted therapeutics.High expression of heat shock protein 90 is associated with tumor aggressiveness and poor prognosis in patients with advanced gastric cancer.17-allyamino-17-demethoxygeldanamycin treatment results in a magnetic resonance spectroscopy-detectable elevation in choline-containing metabolites associated with increased expression of choline transporter SLC44A1 and phospholipase A2Fever-range hyperthermia vs. hypothermia effect on cancer cell viability, proliferation and HSP90 expression.Investigation of anti-cancer mechanisms by comparative analysis of naked mole rat and rat.Trianthema portulacastrum Linn. displays anti-inflammatory responses during chemically induced rat mammary tumorigenesis through simultaneous and differential regulation of NF-κB and Nrf2 signaling pathways.Expression of heat-shock protein gp96 in gallbladder cancer and its prognostic clinical significance.
P2860
Q21195216-5183863C-1651-40A9-98B5-27DAECD923E7Q24273349-E6C561F3-C2AC-4992-9F6D-6929DE253D78Q26765447-09C193B9-26AE-4F0C-956E-17BF114BF666Q27851619-4FAEC5D4-A423-447E-AB1D-95A0020C3008Q27853356-D2D2073A-F1EF-4C05-9604-E54DE952EF4FQ28072513-4B350FF2-2F04-4B6E-85FC-68745643ED6CQ28264693-FDEEF842-1CE4-4021-8170-5625E40F2491Q28265268-7D8AC42E-22B9-46FE-9A93-A8EDCCE98C7DQ28284160-74E50DA0-5355-4E80-A266-CD805055A2DFQ28553354-95AEB131-529F-4419-9314-06C5C1A69939Q30418605-C421B1B8-EFFE-442B-8D27-F3A442B5FD02Q30805174-041CF434-9440-432E-85E5-4937E1B6961AQ33379951-867FDA2D-5D80-4A71-A9FE-6DA76F0351DFQ33551458-9BF2F412-8925-4FBC-899A-D81984D1CD47Q33580353-91DA139A-F6D6-48D1-B713-F1B7B6754568Q33597951-726EA8C3-7439-4067-BA26-88ACAD333F27Q33625453-315DE540-92F6-4F78-BBBB-6319FF7664C7Q33651638-3A1B1367-004F-4C9B-8F77-2C886C9E1C75Q33668999-769029EB-2EA8-4189-B964-37AD34605009Q33676779-1932F9E4-0A1B-4002-A6EB-EDA87D36D212Q33688907-31F74F17-17DA-4735-8DC6-926C996D5ECCQ33785608-ED5A5C73-4121-4C5A-A6EC-578739098DBAQ33812240-59EF55F1-81E8-4B72-8CDA-60B6F537616BQ33823200-DC1F420A-419E-4B7A-ADEB-A63C06A4CBB3Q33889501-D0D7194A-7DD4-4D97-9B8F-E5CE68449B35Q33915037-013FF4F4-31CB-46E6-9034-ED5AFE0CCB6BQ34056376-F73492C8-901E-4741-BE4B-E2B5AD33C3A3Q34140962-373CF153-2436-4565-AB4B-772726AD343AQ34170410-E3F59E1A-F303-44F6-BBF7-97D52A550443Q34326536-93E75501-8E25-4E4B-95B9-A96E9E267000Q34337304-5F63497B-8B4D-4C7F-8FD6-1E68604F2DBEQ34427505-7D224205-9F4F-4C3F-B3FE-6F1F743774A5Q34555318-81362B3E-214B-445E-9C01-FC3BDEEF7410Q34692233-4A459ADB-A89E-4D16-9FE7-5A67901AD008Q34702116-25983D84-895E-44CD-A1CA-A7845B070B42Q34989144-37CF71E9-6043-4C80-92EB-E02E8DBEB0A6Q35032248-BDC488C5-50C2-4B6F-AFEE-373B3B08D934Q35102038-0BF236C6-A689-43EF-B02A-8D6B8A9912BFQ35138880-99F980A6-9812-41FB-8ED0-6DDF26427EC2Q35404849-669C961F-3E5D-4BE4-8FB1-5500CB2062E4
P2860
High HSP90 expression is associated with decreased survival in breast cancer.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
High HSP90 expression is associated with decreased survival in breast cancer.
@en
type
label
High HSP90 expression is associated with decreased survival in breast cancer.
@en
prefLabel
High HSP90 expression is associated with decreased survival in breast cancer.
@en
P2093
P1433
P1476
High HSP90 expression is associated with decreased survival in breast cancer.
@en
P2093
Christopher Moeder
David L Rimm
Harriet M Kluger
Jennifer M Giltnane
Robert L Camp
Yuval Kluger
P304
P356
10.1158/0008-5472.CAN-06-4511
P407
P577
2007-04-01T00:00:00Z